We are proud to announce that Indigo Diabetes NV has been selected as one of just 65 startups to join the prestigious 2025 MedTech Innovator Accelerator Cohort.
Chosen from a pool of nearly 1,500 global applicants, this places us among the top 4% of emerging medtech innovators worldwide.
This recognition is a powerful endorsement of our mission to bring transformative diabetes technology to life. We are honoured to be part of a program that supports breakthrough medical technologies and helps scale innovations that improve patient care.
We are deeply grateful to the mentors, investors, and reviewers who share our vision and continue to support our journey. A heartfelt thank you to MedTech Innovator for this incredible opportunity, we’re excited to take this next step in advancing healthcare together.